DISCLOSEDQuarterly
Polen Capital Management
Protagonist Therapeutics Inc · NASDAQ
22,651 sh · $2.8M
Filed 30 Jun 2026SEC 13Fview source
BlackRock
13F filer
$199.5M
5,758,112 sh
Duquesne Family Office
13F filer
$25.6M
208,900 sh
Soros Fund Management
13F filer
$8.7M
100,000 sh
Polen Capital Management
13F filer
$2.8M
22,651 sh
Bridgewater Associates
13F filer
$556.1K
5,276 sh
Polen Capital Management
Protagonist Therapeutics Inc · NASDAQ
22,651 sh · $2.8M
Duquesne Family Office
Protagonist Therapeutics Inc · NASDAQ
208,900 sh · $25.6M
Bridgewater Associates
Protagonist Therapeutics Inc · NASDAQ
5,276 sh · $556.1K
Duquesne Family Office
Protagonist Therapeutics Inc · NASDAQ
159,700 sh · $16.8M
Polen Capital Management
Protagonist Therapeutics Inc · NASDAQ
24,337 sh · $2.6M
Polen Capital Management
Protagonist Therapeutics Inc · NASDAQ
20,349 sh · $1.8M
Duquesne Family Office
Protagonist Therapeutics Inc · NASDAQ
159,700 sh · $13.9M
Soros Fund Management
Protagonist Therapeutics Inc · NASDAQ
100,000 sh · $8.7M
Polen Capital Management
Protagonist Therapeutics Inc · NASDAQ
20,325 sh · $1.4M
Duquesne Family Office
Protagonist Therapeutics Inc · NASDAQ
159,700 sh · $10.6M